Komori
Nichiban (4218) · PolicyMitigated

Maintaining the Brand and Strengthening the Earnings Structure

First written in FY2016. 14 of 28 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-11-12.

28entries
11years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017 – FY2019AdvancedFY2021-Q3 – FY2023-Q12016: 320162017: 320172018: 020182019: 220192020: 220202021: 420212022: 320222023: 320232024: 220242025: 120252026: 52026
Same theme, other companies
Maintaining the Brand and Strengthening the Earnings StructureA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「Partly due to the effects of price revisions for “TabanelaTM Tape” and other factors, segment profit amounted to ¥828 million, up 17.2% year on year.」

    In response to deterioration in the Tape Business earnings structure, segment profit improved by 17.2% year on year through price revisions and other measures.
  2. 2026-05-14MitigatedResults

    「Partly due to the effects of price revisions for “TabanelaTM Tape” and other factors, segment profit amounted to ¥828 million, up 17.2% year on year.」

    テープ事業のセグメント利益は前年同期比で増加し、収益性の悪化傾向が一部低減している。
  3. FY2026-H1WorsenedAnnual report

    「Segment profit amounted to ¥361 million, down 8.1% year on year, due mainly to higher sales volumes of low-margin products.」

    In the Tape Business, segment profit fell 8.1% year on year due mainly to higher sales volumes of low-margin products, reflecting deterioration in the earnings structure.
  4. FY2025-H1AdvancedAnnual report

    「Total sales in the Tape Business amounted to ¥11,951 million, up 3.1% year on year. Segment profit was ¥393 million, compared with a segment loss of ¥124 million in the year-earlier period, due mainly to the effects of price revisions implemented continuously since the previous fiscal year.」

    Strengthening the Tape Business earnings structure was reflected in continued price revisions and a turnaround from segment loss to ¥393 million in profit.
  5. FY2024-Q3WorsenedAnnual report

    「Total sales in the Tape Business amounted to ¥18,057 million, down 1.7% year on year. Segment loss was ¥25 million, compared with segment profit of ¥884 million in the year-earlier period, due mainly to higher raw material unit prices resulting from the rise in naphtha prices and other factors.」

    While strengthening brands and the earnings structure, the Tape Business posted lower sales and deteriorated from segment profit in the year-earlier period to a ¥25 million loss.
  6. FY2024-Q2AdvancedAnnual report

    「The profitability of the Tape Business has deteriorated due to soaring raw material prices and other factors. To improve this situation, we will pursue various measures, including price revisions for unprofitable products, further efficiency improvements in the Tape Business production structure, and measures to expand sales of new and existing products.」

    In response to the deterioration in Tape Business profitability, the previous policy of maintaining brands and strengthening the earnings structure has taken concrete form through price revisions for unprofitable products, production efficiency improvements, and measures to expand sales of new and existing products.
  7. FY2024-Q1RestatedAnnual report

    「Execution of strategy under a customer-focused business execution structure, thorough selection and concentration in business processes and activities, and promotion of efficiency improvements」

    We continue to pursue earnings reform through customer-focused business execution, selection and concentration in operations, and efficiency improvements.
  8. FY2023-Q3AdvancedAnnual report

    「In the e-commerce market, amid the challenging sales environment, with weak demand for office supplies continuing, demand for consumables such as “Cellotape®” and the double-sided tape “NicetackTM” remained strong as we proceeded with price revisions and strengthened web marketing for online purchasing. As a result, sales in the e-commerce field for the Tape Business amounted to ¥2,501 million, up 7.1% year on year.」

    Measures to strengthen the earnings structure and brands took concrete form through price revisions and web marketing for e-commerce, with Tape Business e-commerce field sales up 7.1% year on year.
  9. FY2023-Q2RestatedAnnual report

    「Amid the challenging sales environment, with weak demand for office supplies continuing, we proceeded with price revisions and strengthened web marketing for online purchasing in e-commerce. As a result, sales in the e-commerce field for the Tape Business exceeded the year-earlier period.」

    We continued to strengthen earnings and brands through price revisions and web marketing for e-commerce, and e-commerce field sales in the Tape Business exceeded the year-earlier period.
  10. FY2023-Q1AdvancedAnnual report

    「In e-commerce, we strengthened web marketing for online purchasing. Despite the challenging sales environment, with weak demand for office supplies continuing, sales across the e-commerce field exceeded the year-earlier period as we improved the shopping experience, particularly in e-commerce, by enhancing product brand information and making products easier for customers to choose and understand.」

    Measures to strengthen the earnings structure and brands have taken concrete form through web marketing for e-commerce, expanded product brand information, and improvements to make the shopping experience easier, with e-commerce field sales exceeding the year-earlier period.
  11. FY2022AdvancedAnnual report

    「Reorganization of the sales and marketing organization to promote businesses centered on customers」

    Customer-focused sales execution and earnings reform are being implemented through organizational restructuring, including the Consumer Sales Division, E-Commerce Sales Management Division, Industrial Products Sales Management Division, and Medical Materials Sales Management Division.
  12. FY2022-Q2AdvancedAnnual report

    「To strengthen the new customer-focused sales execution structure and rebuild our brand strategy, we established the Consumer Sales Division, with the Healthcare Sales Management Division and Office/Home Sales Management Division under it. We also established the independent E-Commerce Sales Management Division under the Consumer Sales Division, formerly part of the Special E-Commerce Sales Department, to actively expand e-commerce sales, including cross-border e-commerce.」

    The customer-focused sales reorganization is taking concrete form through the establishment of the Consumer Sales Division, sales management divisions by sales channel, and the E-Commerce Sales Management Division, including cross-border e-commerce.
  13. FY2022-Q1AdvancedAnnual report

    「To strengthen business activities centered on customers, from the current fiscal year we abolished the Tape Business Division and Medical Business Division, placed sales operations under the Domestic Business Division and Overseas Business Division, and established the following sales management divisions under the Domestic Business Division by sales channel.」

    To promote customer-focused businesses and reform earnings, the former business-division structure is being abolished and the organization is being restructured into domestic and overseas business divisions and sales management divisions by sales channel.
  14. FY2021AdvancedAnnual report

    「The sales and marketing organization was restructured effective 1 April 2021.」

    The previous policy of maintaining brands and strengthening the earnings structure has moved into the implementation phase through the establishment of the Consumer Sales Division, customer-focused sales for the B2B business, price revisions for unprofitable products, and a review of logistics cost management.
  15. FY2021-Q3AdvancedAnnual report

    「As a result of activities to help government agencies and other users understand that “Cellotape®” is an environmentally friendly product made from natural materials, sales exceeded the year-earlier period in both cases.」

    Activities were conducted to promote the environmentally friendly characteristics of Cellotape to government agencies and others, and sales exceeded the year-earlier period.
  16. FY2020ReframedAnnual report

    「③ Review of the business execution structure and earnings reform *Review of the customer-focused business execution structure *Scrap-and-build of products and activities from the perspectives of operating profit and future business potential, and review of the special-sales business *Optimal allocation of management resources (capital investment and personnel deployment)」

    The previous policy of maintaining brands and strengthening the earnings structure has been reorganized under ISHIZUE 2023 into a customer-focused organizational review, scrap-and-build of products and activities, a review of the special-sales business, and optimization of capital investment and personnel deployment.
  17. FY2020-Q3AdvancedAnnual report

    「Sales of Cellotape® exceeded the previous year as the Company expanded sales of value-added products, including Cellotape® Mini Cutter with Straight-Cut Function, to major chains.」

    The Company expanded sales of value-added Cellotape products to major chains and stated that sales exceeded the previous year.
  18. FY2020-Q1RestatedAnnual report

    「For packaging tape, the price revisions implemented in the previous fiscal year continued to improve margins, but demand recovery remained sluggish and sales were below the previous year.」

    The Company continued to report the margin improvement resulting from the packaging tape price revisions implemented in the previous fiscal year.
  19. FY2019AdvancedAnnual report

    「The Company implemented price revisions for Cellotape® and packaging tape products, contributing to improved profitability.」

    The Company implemented price revisions for Cellotape and packaging tape, stating that they contributed to improved profitability.
  20. FY2018-Q1AdvancedAnnual report

    「For corrugated-box packaging tape products, the Company reviewed transactions at unprofitable selling prices during the previous fiscal year, resulting in a decline in some sales. During the three-month period ended [first quarter], however, it resumed sales activities targeting new customers to seek a recovery.」

    The Company stated that it resumed sales activities targeting new customers to recover sales after reviewing transactions at unprofitable selling prices.
  21. FY2017AdvancedAnnual report

    「Profit in this business field increased as the Company reviewed unprofitable sales of packaging tape products and improved production efficiency.」

    The Company reviewed sales profitability and improved production efficiency, reporting increased profit in the Industrial Products field.
  22. FY2017-Q3RestatedAnnual report

    「Cellotape®, the flagship product, continued to perform steadily under the sales strategy aimed at building an earnings base. However, sales were slightly below the previous year because the recovery in demand for packaging tape products, whose sales rollout was being advanced while strengthening profitability reviews, stalled. Nevertheless, profit in this business field increased as a result of advancing production efficiency and the sales strategy.」

    The Company described continued efforts on Cellotape's sales strategy, production efficiency, and profitability reviews, which increased profit in the Industrial Products field.
  23. FY2017-Q2RestatedAnnual report

    「Cellotape®, the flagship product, continued to be supported by a sales strategy aimed at building an earnings base, and sales progressed steadily.」

    The Company continued its sales strategy aimed at building an earnings base and stated that Cellotape sales progressed steadily.
  24. FY2017-Q1AdvancedAnnual report

    「As a result of strongly pursuing a sales strategy to build an earnings base, sales of Cellotape™ remained firm.」

    The Company strongly pursued a sales strategy aimed at building an earnings base and stated that Cellotape sales remained firm.
  25. FY2016First statedAnnual report

    「The basic strategy is to maintain and enhance the brand and strengthen the earnings structure.」

    The basic strategy calls for simultaneously strengthening the brand and earnings structure through execution of strategies at the business-field level.
Moved together

"International Expansion of Medical Products in Asia and Europe" moved the same way as this thread, in the same document, in 12 of its 28 moves.

121111966★123456
  1. ★This thread
  2. 1International Expansion of Medical Products in Asia and Europe12×
  3. 2Strengthening efforts to raise product brand awareness and promote sales11×
  4. 3Cost Reduction, Environmental Initiatives and Crisis Management through Large-Scale Capital Investment11×
  5. 4Creation of Major Development Products9×
  6. 5Strengthening Research into Adhesives, Transdermal Absorption and Environmental Technologies6×
  7. 6Expanding Global Operations through Business Alliances and M&A6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Nichiban's next results are scheduled for 2026-11-12. Read the earnings preview It last moved in the Results of 2026-11-12: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.